Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01451853
Recruitment Status : Unknown
Verified September 2017 by Sound Pharmaceuticals, Incorporated.
Recruitment status was:  Not yet recruiting
First Posted : October 14, 2011
Last Update Posted : September 25, 2017
Sponsor:
Collaborator:
VA Puget Sound Health Care System
Information provided by (Responsible Party):
Sound Pharmaceuticals, Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 26, 2019
Estimated Study Completion Date : September 23, 2019
Publications:
Lynch E, Kil J. Development of Ebselen, a Glutathione Peroxidase Mimic, for the Prevention and Treatment of Noise-Induced Hearing Loss. Semin Hear 2009; 30(1): 047-055